Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study.
Rikshospitalet University Hospital.
Linköpings universitet.
Karlstads universitet.ORCID-id: 0000-0002-3356-9952
Ulleval University Hospital.
2004 (Engelska)Ingår i: Journal of Investigative Dermatology, ISSN 0022-202X, E-ISSN 1523-1747, Vol. 122, nr 3, s. 587-93Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Based on previous experience with parenteral prostanoids, we studied the effect of misoprostol treatment, an orally administered prostaglandin E1 analog, in patients with erythromelalgia. Treatment with placebo was followed by treatment with misoprostol (0.4-0.8 mg per d), both for 6 wk. The patients (n=21) and a study nurse who administered the trial were blinded. The endpoints were change in pain and need for cooling and global assessment of the treatment. Following central body heat provocation, global skin perfusion, capillary morphology, and change in pain were also recorded before and after each treatment period. Results were compared with data from healthy control subjects (n=11) that did not undergo treatment. Clinical safety and tolerability evaluation included physical examinations, clinical laboratory tests, and monitoring of adverse events. All clinical outcome measures were significantly better after treatment with misoprostol (p<0.01) as compared with placebo treatment and after a 3- mo follow-up without treatment. The heat-induced increase in global perfusion after misoprostol treatment was similar to the control group and significantly lower when compared with baseline (p<0.01) and placebo treatment (p<0.05), respectively. This study demonstrates that misoprostol is clinically superior to placebo in patients with erythromelalgia. The results of the perfusion studies may imply that the mechanism of action of the beneficial effect of misoprostol is reduced microvascular arteriovenous shunting in affected skin.

Ort, förlag, år, upplaga, sidor
2004. Vol. 122, nr 3, s. 587-93
Nationell ämneskategori
Datorseende och robotik (autonoma system)
Forskningsämne
Biomedicinsk lab. Vetenskap
Identifikatorer
URN: urn:nbn:se:kau:diva-3195DOI: 10.1111/j.0022-202X.2004.22339.xPubMedID: 15086539OAI: oai:DiVA.org:kau-3195DiVA, id: diva2:128368
Tillgänglig från: 2008-12-16 Skapad: 2008-12-16 Senast uppdaterad: 2018-01-13Bibliografiskt granskad

Open Access i DiVA

fulltext(350 kB)699 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 350 kBChecksumma SHA-512
ff9d8760ba48a752437a811b346a34cba38acd7cc2da578da8b01b64ea0b88681f39eb94eda865b33532794979ab4eb86ede07dff5f95f1ddf99aff80277ffce
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedhttp://www.nature.com/jid/journal/v122/n3/full/5602219a.html

Personposter BETA

Asker, Claes L

Sök vidare i DiVA

Av författaren/redaktören
Asker, Claes L
Av organisationen
Karlstads universitet
I samma tidskrift
Journal of Investigative Dermatology
Datorseende och robotik (autonoma system)

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 699 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 356 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf